Literature DB >> 25554744

CDK6 is a regulator of stem cells "Egr" to wake up.

Monica L Guzman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25554744      PMCID： PMC4281831          DOI： 10.1182/blood-2014-11-609230

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6.

Authors:  Marcos Malumbres; Rocío Sotillo; David Santamaría; Javier Galán; Ana Cerezo; Sagrario Ortega; Pierre Dubus; Mariano Barbacid
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

2.  Awakening dormant haematopoietic stem cells.

Authors:  Andreas Trumpp; Marieke Essers; Anne Wilson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

Review 3.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

4.  Scheicher R, Hoelbl-Kovacic A, Bellutti F, et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Blood. 2015;125(1):90-101.

Authors: 
Journal:  Blood       Date:  2018-08-30       Impact factor: 22.113

5.  The cancer drug that almost wasn't.

Authors:  Ken Garber
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

Review 6.  Concise review: Leukemia stem cells in personalized medicine.

Authors:  Monica L Guzman; John N Allan
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

7.  A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.

Authors:  Miaofen G Hu; Amit Deshpande; Miriam Enos; Daqin Mao; Elisabeth A Hinds; Guo-fu Hu; Rui Chang; Zhuyan Guo; Marei Dose; Changchuin Mao; Philip N Tsichlis; Fotini Gounari; Philip W Hinds
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

8.  The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells.

Authors:  Irene M Min; Giorgio Pietramaggiori; Francis S Kim; Emmanuelle Passegué; Kristen E Stevenson; Amy J Wagers
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

9.  Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.

Authors:  Theresa Placke; Katrin Faber; Atsushi Nonami; Sarah L Putwain; Helmut R Salih; Florian H Heidel; Alwin Krämer; David E Root; David A Barbie; Andrei V Krivtsov; Scott A Armstrong; William C Hahn; Brian J Huntly; Stephen M Sykes; Michael D Milsom; Claudia Scholl; Stefan Fröhling
Journal:  Blood       Date:  2014-04-24       Impact factor: 22.113
  9 in total
  4 in total

Review 1.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

2.  Another piece of the puzzle added to understand t(4;11) leukemia better.

Authors:  Rolf Marschalek
Journal:  Haematologica       Date:  2019-06       Impact factor: 9.941

3.  CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.

Authors:  Yao Fan; Haiping Li; Xiaolong Liang; Zheng Xiang
Journal:  Oncotarget       Date:  2017-03-21

Review 4.  The role of CDK6 in cancer.

Authors:  Sofie Nebenfuehr; Karoline Kollmann; Veronika Sexl
Journal:  Int J Cancer       Date:  2020-05-30       Impact factor: 7.396
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.